JULIE GEBHARDT: Open Payments
NPI 1003563214 · SCHAUMBURG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,014 in 14 payments from 8 companies in 2025. Trend: 2023 $3,213 · 2024 $1,818 · 2025 $2,014
Food & beverage: $1,352Consulting: $630Travel & lodging: $32
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $1,048 |
| Pulmonx Corporation | 2 | $300 |
| AstraZeneca Pharmaceuticals LP | 1 | $128 |
| Lilly USA, LLC | 1 | $125 |
| Verona Pharma, Inc. | 1 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $106 |
| Axsome Therapeutics, Inc. | 1 | $102 |
| GlaxoSmithKline, LLC. | 1 | $84 |
Products named: CHARTIS CATHETER, DUPIXENT, TEZSPIRE, ZEPBOUND, Ohtuvayre, OFEV, Sunosi, NUCALA.
Industry payments across IL — which companies pay providers there.
